These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3398853

  • 1. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
    Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS.
    Mol Endocrinol; 1988 Mar; 2(3):263-71. PubMed ID: 3398853
    [Abstract] [Full Text] [Related]

  • 2. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD, Greene GL, Katzenellenbogen BS.
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [Abstract] [Full Text] [Related]

  • 3. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
    Read LD, Keith D, Slamon DJ, Katzenellenbogen BS.
    Cancer Res; 1990 Jul 01; 50(13):3947-51. PubMed ID: 1972345
    [Abstract] [Full Text] [Related]

  • 4. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB.
    Endocrinology; 1985 Jun 01; 116(6):2236-45. PubMed ID: 4039656
    [Abstract] [Full Text] [Related]

  • 5. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.
    Berkenstam A, Glaumann H, Martin M, Gustafsson JA, Norstedt G.
    Mol Endocrinol; 1989 Jan 01; 3(1):22-8. PubMed ID: 2915647
    [Abstract] [Full Text] [Related]

  • 6. Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells.
    Wei LL, Krett NL, Francis MD, Gordon DF, Wood WM, O'Malley BW, Horwitz KB.
    Mol Endocrinol; 1988 Jan 01; 2(1):62-72. PubMed ID: 3398843
    [Abstract] [Full Text] [Related]

  • 7. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D, Zava DT, Speers WC, Edwards DP.
    Cancer Res; 1988 Nov 15; 48(22):6462-74. PubMed ID: 3180062
    [Abstract] [Full Text] [Related]

  • 8. Progesterone agonists and antagonists induce down- and up-regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines.
    Savoldi G, Ferrari F, Ruggeri G, Sobek L, Albertini A, Di Lorenzo D.
    Int J Biol Markers; 1995 Nov 15; 10(1):47-54. PubMed ID: 7629427
    [Abstract] [Full Text] [Related]

  • 9. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S, Marsaud V, Mercier-Bodard C, Baulieu EE, Mader S, White JH, Renoir JM.
    Mol Endocrinol; 1998 Jul 15; 12(7):986-1001. PubMed ID: 9658403
    [Abstract] [Full Text] [Related]

  • 10. Expression and regulation of retinoic acid receptors in human breast cancer cells.
    Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL.
    Cancer Res; 1992 Apr 15; 52(8):2236-42. PubMed ID: 1313739
    [Abstract] [Full Text] [Related]

  • 11. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB.
    Cancer Res; 1994 Jul 15; 54(14):3868-77. PubMed ID: 8033109
    [Abstract] [Full Text] [Related]

  • 12. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 13. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC, Katzenellenbogen BS.
    Cancer Res; 1986 Mar 15; 46(3):1124-31. PubMed ID: 3943090
    [Abstract] [Full Text] [Related]

  • 14. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
    Nardulli AM, Katzenellenbogen BS.
    Endocrinology; 1988 Apr 15; 122(4):1532-40. PubMed ID: 3345726
    [Abstract] [Full Text] [Related]

  • 15. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels.
    Ree AH, Landmark BF, Eskild W, Levy FO, Lahooti H, Jahnsen T, Aakvaag A, Hansson V.
    Endocrinology; 1989 May 15; 124(5):2577-83. PubMed ID: 2651098
    [Abstract] [Full Text] [Related]

  • 16. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X, Lazard Z, Zhang P, Hopp TA, Lee AV.
    Oncogene; 2003 Oct 09; 22(44):6937-41. PubMed ID: 14534541
    [Abstract] [Full Text] [Related]

  • 17. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
    Kraus WL, Katzenellenbogen BS.
    Endocrinology; 1993 Jun 09; 132(6):2371-9. PubMed ID: 8504742
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
    Gupta A, Mehta R, Alimirah F, Peng X, Murillo G, Wiehle R, Mehta RG.
    J Steroid Biochem Mol Biol; 2013 Jan 09; 133():30-42. PubMed ID: 22939887
    [Abstract] [Full Text] [Related]

  • 19. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH, Parker CJ, Jordan VC.
    Cancer Res; 1992 Dec 01; 52(23):6539-46. PubMed ID: 1423300
    [Abstract] [Full Text] [Related]

  • 20. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
    Anticancer Res; 2006 Dec 01; 26(3A):1773-84. PubMed ID: 16827106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.